Skip to main content
Log in

Variations of retinol binding protein 4 levels are not associated with changes in insulin resistance during puberty

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Retinol binding protein 4 (RBP4) is an adipokine involved in the pathogenesis of insulin resistance in obese adults and children. Since insulin resistance occurs during puberty, independently of adiposity, a role for RBP4 in the onset of this phenomenon may be hypothesized. In order to verify our hypothesis, we studied 90 subjects (45 obese and 45 lean controls). A complete physical examination was assessed, the z-score body mass index (BMI) was calculated, fat mass was assessed by bioelectric impedance analysis, and pubertal stage was assessed according to Tanner. Serum insulin and serum RBP4 levels were assayed. Obese and lean children differed for z-score BMI, fat mass, homeostasis model assessment of insulin resistance (HOMA-IR) and RBP4 levels. z-score BMI and HOMA-IR showed a direct correlation with RBP4 in the total population. When the subjects were divided in lean and obese, this correlation was evident only in obese (r2: 0.2; p=0.009 and r2: 0.2; p=0.01), but not in lean subjects (r2: 0.09; p=0.1 and r2: 0.03; p=0.4). Both in obese and lean HOMA-IR values were higher in pubertal subjects than in pre-pubertal (p<0.001), while serum RBP4 levels were similar in pubertal and in pre-pubertal subjects (>0.1). We conclude that RBP4 is correlated with adiposity and insulin resistance in obese children, but it is not involved in the insulin resistance occurring during puberty.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006, 29: 427–32.

    Article  Google Scholar 

  2. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in preadolescent obese children. Diabetologia 1996, 39: 1489–97.

    Article  PubMed  CAS  Google Scholar 

  3. Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999, 48: 2039–44.

    Article  PubMed  CAS  Google Scholar 

  4. Caprio S, Cline G, Boulware S, et al. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels. Am J Physiol 1994, 266: E885–91.

    PubMed  CAS  Google Scholar 

  5. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 2001, 50: 2444–50.

    Article  PubMed  CAS  Google Scholar 

  6. Ball GD, Huang TT, Gower BA, et al. Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty. J Pediatr 2006, 148: 16–22.

    Article  PubMed  CAS  Google Scholar 

  7. Hoffman RP, Vicini P, Sivitz WI, Cobelli C. Pubertal adolescent malefemale differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model. Pediatr Res 2000, 48: 384–8.

    Article  PubMed  CAS  Google Scholar 

  8. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 1995, 80: 172–8.

    PubMed  CAS  Google Scholar 

  9. Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999, 48: 2039–44.

    Article  PubMed  CAS  Google Scholar 

  10. Ball GD, Huang TT, Gower BA, et al. Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty. J Pediatr 2006, 148: 16–22.

    Article  PubMed  CAS  Google Scholar 

  11. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003, 88: 1417–27.

    Article  PubMed  CAS  Google Scholar 

  12. Graham TE, Yang Q, Blüher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354: 2552–63.

    Article  PubMed  CAS  Google Scholar 

  13. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436: 356–62.

    Article  PubMed  CAS  Google Scholar 

  14. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007, 92: 1971–4.

    Article  PubMed  CAS  Google Scholar 

  15. Aeberli I, Biebinger R, Lehmann R, L’allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab 2007, 92: 4359–65.

    Article  PubMed  CAS  Google Scholar 

  16. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51: 170–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990, 44: 45–60.

    PubMed  CAS  Google Scholar 

  18. Luciano A, Bressan F, Zoppi G. Body mass index reference curves for children aged 3–19 years from Verona, Italy. Eur J Clin Nutr 1997, 51: 6–10.

    Article  PubMed  CAS  Google Scholar 

  19. Santoro N, Perrone L, Cirillo G, et al. Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am J Clin Nutr 2007, 85: 950–3.

    PubMed  CAS  Google Scholar 

  20. Santoro N, Cirillo G, Amato A, et al. Insulin gene variable number of tandem repeats (INS VNTR) genotype and metabolic syndrome in childhood obesity. J Clin Endocrinol Metab 2006, 91: 4641–4.

    Article  PubMed  CAS  Google Scholar 

  21. Gavi S, Stuart LM, Kelly P, et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 2007, 9: 1886–90.

    Article  CAS  Google Scholar 

  22. Vitkova M, Klimcakova E, Kovacikova M, et al. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinolbinding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab 2007, 92: 2330–5.

    Article  PubMed  CAS  Google Scholar 

  23. Tamori Y, Sakaue H, Kasuga M. RBP4, an unexpected adipokine. Nat Med 2006, 12: 30–1.

    Article  PubMed  CAS  Google Scholar 

  24. Chiarelli F, Giannini C, Mohn A. Growth, growth factors and diabetes. Eur J Endocrinol 2004, 151 (Suppl): U109–17.

    Article  PubMed  CAS  Google Scholar 

  25. Yamauchi J, Osawa H, Takasuka T, et al. Serum resistin is reduced by glucose and meal loading in healthy human subjects. Metabolism 2008, 57: 149–56.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. Miraglia del Giudice MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santoro, N., Perrone, L., Cirillo, G. et al. Variations of retinol binding protein 4 levels are not associated with changes in insulin resistance during puberty. J Endocrinol Invest 32, 411–414 (2009). https://doi.org/10.1007/BF03346477

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346477

Key-words

Navigation